Allergan is buying DERMATOLOGY companies to expand their pipeline.... hmmm, what company do we know that's working on dermatological drugs? And has a newly-hired experienced guy at the helm? I wonder....

http://www.fiercebiotech.com/biotech/allergan...ajA9In0%3D

Quote:

---

The deal, worth $21 a share, is a major premium on the $8 a share it was trading on last night before the acquisition was announced, when it had a market cap of $238 million.

---